Scott Brown

Director of Finance/CFO presso TRACON PHARMACEUTICALS, INC.

Patrimonio netto: 10 805 $ in data 31/03/2024

43 anni

73 relazioni

Health Technology

Consumer Services

Commercial Services

Profilo

Scott B.
Brown is currently the Chief Financial Officer at TRACON Pharmaceuticals, Inc. He previously worked as the Associate Director-Finance at Ardea Biosciences, Inc. from 2013 to 2015, Finance Manager at SciClone Pharmaceuticals LLC from 2011 to 2012, Finance Manager at Exelixis, Inc. from 2009 to 2011, and Audit Associate at KPMG LLP in 2008.
He holds a graduate degree from San Diego State University and an undergraduate degree from the University of California.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
TRACON PHARMACEUTICALS, INC. 0.06%	12/03/2024	25 128 ( 0.06% )	10 805 $	31/03/2024

Posizioni attive di Scott Brown

Società	Posizione	Inizio
TRACON PHARMACEUTICALS, INC.	Director of Finance/CFO	29/01/2021

Tutte le posizioni attive di Scott Brown

Precedenti posizioni note di Scott Brown

Società	Posizione	Fine
Ardea Biosciences, Inc. Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.	Director of Finance/CFO	01/01/2015
SCICLONE PHARMACEUTICALS, INC.	Director of Finance/CFO	01/01/2012
EXELIXIS, INC.	Director of Finance/CFO	01/01/2011
KPMG LLP KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY.	Corporate Officer/Principal	01/06/2008

Vedi nel dettaglio l'esperienza di Scott Brown

Formazione di Scott Brown

San Diego State University	Graduate Degree
University of California	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Scott Brown

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
EXELIXIS, INC.	Health Technology
TRACON PHARMACEUTICALS, INC.	Health Technology

Aziende private	3
SciClone Pharmaceuticals LLC SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA.	Health Technology
KPMG LLP KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY.	Commercial Services
Ardea Biosciences, Inc. Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.	Health Technology

Vedi le connessioni aziendali